Hannah is a Senior Scientist in our Innovation team. After completing an MSc in Genetics and Genomics, Hannah worked in process development in cancer cell therapy research before joining RoukenBio in 2020.
Resources
Research Posters
17 August 2026
|4 min read
This research poster presents a high-throughput, patient-derived colorectal cancer tumoroid platform incorporating autologous fibroblasts and tumour-infiltrating lymphocytes. By combining genomic, gene-expression and drug-response data, the model captures patient-specific tumour heterogeneity and supports translational drug discovery, predictive biomarker identification and immunotherapy research.
Research Posters
22 October 2025
|4 min read
Antigen-specific T cells are essential for evaluating immune-modulating therapies, but sourcing them for research is challenging. This blog highlights the development of ‘Thaw & Go’ transgenic TCR-T cell banks and methods to expand endogenous antigen-specific T cells, providing ready-to-use resources for high-throughput assessment of immune modulators and advancing drug discovery efforts.
Research Posters
16 July 2025
|5 min read
Understanding how antibody-based drugs interact with targets at different expression levels is key to optimising their safety and efficacy. Traditional methods struggle to measure binding kinetics in real cellular environments. This study uses the IndEx-2 system and single-cell Interaction Cytometry to reveal how target density affects drug binding in a more physiologically relevant context.
